No abstract available
MeSH terms
-
Amenorrhea / chemically induced
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bleomycin / administration & dosage
-
Bleomycin / adverse effects
-
Brentuximab Vedotin
-
Cause of Death
-
Climacteric / drug effects
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / adverse effects
-
Dacarbazine / administration & dosage
-
Dacarbazine / adverse effects
-
Dose-Response Relationship, Drug
-
Doxorubicin / administration & dosage
-
Doxorubicin / adverse effects
-
Drug Administration Schedule
-
Etoposide / administration & dosage
-
Etoposide / adverse effects
-
Female
-
Hodgkin Disease / drug therapy*
-
Hodgkin Disease / mortality
-
Hodgkin Disease / pathology
-
Humans
-
Immunoconjugates / administration & dosage
-
Immunoconjugates / adverse effects
-
Molecular Targeted Therapy
-
Neoplasm Staging
-
Prednisone / administration & dosage
-
Prednisone / adverse effects
-
Procarbazine / administration & dosage
-
Procarbazine / adverse effects
-
Vinblastine / administration & dosage
-
Vinblastine / adverse effects
-
Vincristine / administration & dosage
-
Vincristine / adverse effects
Substances
-
Immunoconjugates
-
Bleomycin
-
Procarbazine
-
Vincristine
-
Vinblastine
-
Etoposide
-
Dacarbazine
-
Brentuximab Vedotin
-
Doxorubicin
-
Cyclophosphamide
-
Prednisone
Supplementary concepts
-
ABVD protocol
-
BEACOPP protocol